These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 765871)

  • 21. [Diagnosis of graft rejection].
    Gonnermann D; Tenschert W; Cremaschi L
    Urologe A; 1994 Sep; 33(5):383-7. PubMed ID: 7974926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of immunoregulatory molecules on tubular cells and lymphocytes in fine-needle aspiration biopsy: early diagnostic marker for renal allograft rejection.
    Arndt R; Weiss M; Hammerer P; Huland H; Kruppa A; Krämer-Hansen H
    Transplant Proc; 1988 Aug; 20(4):614-6. PubMed ID: 3136570
    [No Abstract]   [Full Text] [Related]  

  • 23. The diagnosis of renal allograft rejection: an improved assessment of graft infiltration using image analysis.
    Foot RA; Fuggle SV; McWhinnie DL; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1905-6. PubMed ID: 2652621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
    Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
    [No Abstract]   [Full Text] [Related]  

  • 25. Fine needle aspiration biopsy of human renal transplants.
    Nishioka T; Negita M; Ikegami M; Imanishi M; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T
    Transplant Proc; 1992 Aug; 24(4):1551-3. PubMed ID: 1496655
    [No Abstract]   [Full Text] [Related]  

  • 26. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
    Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Echography in the diagnosis of kidney diseases].
    Durante E
    Minerva Med; 1977 Nov; 68(54):3663-8. PubMed ID: 339131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal allograft infiltrate in the absence of rejection.
    Burdick JF; McGraw D; Bender W; Beschorner WE; Williams GM; Solez K
    Transplant Proc; 1984 Dec; 16(6):1580-2. PubMed ID: 6390865
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of fine-needle aspiration biopsy in the diagnosis of acute renal transplant dysfunction.
    Gonçalves LF; Manfro R; Rauber L; Edelweiss M; Prompt C
    Transplant Proc; 1992 Dec; 24(6):3083-4. PubMed ID: 1466065
    [No Abstract]   [Full Text] [Related]  

  • 30. Kidney glomeruli collected by fine needle aspiration biopsy.
    Miller S; Belitsky P; Gupta R
    Transplant Proc; 1989 Aug; 21(4):3614-7. PubMed ID: 2669262
    [No Abstract]   [Full Text] [Related]  

  • 31. Morphologic diagnosis of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Semin Diagn Pathol; 1988 Feb; 5(1):104-21. PubMed ID: 3281200
    [No Abstract]   [Full Text] [Related]  

  • 32. [Percutaneous needle biopsy of kidney after transplantation (author's transl)].
    Guo YL
    Zhonghua Wai Ke Za Zhi; 1980 Oct; 18(5):464-5. PubMed ID: 7014148
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood eosinophilia and major histocompatibility complex II expression in renal allograft rejection.
    Pecorella I; Ciardi A; Pretagostini R; Caricato M; Forti A; Berloco P; Alfani D; Di Tondo U; Cortesini R
    Transplant Proc; 1988 Aug; 20(4):606-7. PubMed ID: 3043813
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fine-needle aspiration and puncture biopsies in the diagnosis of lesions of kidney transplants].
    Rozental' RL; Il'inskiĭ IM; Lazovskis IR; Strokan' VA; Bitsans IaB
    Urol Nefrol (Mosk); 1991; (1):37-40. PubMed ID: 1858204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of fine needle aspiration biopsy in differential diagnosis between nephrotoxicity and rejection.
    Häyry P; von Willebrand E
    Contrib Nephrol; 1986; 51():147-51. PubMed ID: 3105956
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA-DR expression in fine-needle aspiration biopsy cell samples as a marker of rejection in kidney grafts.
    Goldberg J; Rial M; Casadei D; Vila N; Zarazaga CN; Mainetti L
    Transplant Proc; 1988 Aug; 20(4):612-3. PubMed ID: 3043816
    [No Abstract]   [Full Text] [Related]  

  • 37. Fine-needle aspiration cytology during treatment with orthoclone monoclonal antibody OKT3 for acute cellular rejection after renal transplantation.
    Hansen BL; Foged N; Nielsen E; Elbirk A; Rohr N; Svendsen V; Birkeland SA
    Transplant Proc; 1988 Aug; 20(4):626-8. PubMed ID: 2970142
    [No Abstract]   [Full Text] [Related]  

  • 38. [How to manage your patients before percutaneous renal biopsy].
    Nishi S
    Nihon Jinzo Gakkai Shi; 2005; 47(4):411-5. PubMed ID: 15971882
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fine-needle aspiration biopsy in diagnosing the status of renal transplant with delayed function].
    Rozenta'l RL; I'linskiĭ IM; Bitsans IaB; Shu'lman OM; Stroka'n VA
    Khirurgiia (Mosk); 1989 Jun; (6):18-21. PubMed ID: 2674525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The value of kidney biopsy].
    Hoedemaeker J
    Ned Tijdschr Geneeskd; 1983 Nov; 127(46):2101-4. PubMed ID: 6358905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.